Neonatal thrombocytopenia.

Area of Science:

• Neonatal Hematology
• Pediatric Critical Care

Background:

• Thrombocytopenia, defined as platelets <150 x 10(9)/L, is a frequent hematological issue in neonates, especially preterm and critically ill infants.
• Early-onset thrombocytopenia (<72h) in preterm neonates is often linked to reduced platelet production due to intrauterine growth restriction or maternal hypertension.
• Late-onset thrombocytopenia (>72h) in both preterm and term infants commonly results from sepsis or necrotizing enterocolitis.

Purpose of the Study:

• To review the causes and management of neonatal thrombocytopenia.
• To highlight neonatal alloimmune thrombocytopenia (NAIT) as a critical cause of severe thrombocytopenia.
• To emphasize the urgent need for studies on optimal platelet transfusion practices in neonates.

Main Methods:

• Review of existing literature on neonatal thrombocytopenia.
• Analysis of common etiologies based on the timing of onset and gestational age.
• Discussion of treatment modalities, particularly platelet transfusion.

Main Results:

• Identified distinct causes for early-onset versus late-onset neonatal thrombocytopenia.
• Highlighted NAIT as a significant cause of severe thrombocytopenia with potential for serious complications like intracranial hemorrhage.
• Noted the lack of clear correlation between thrombocytopenia severity and bleeding risk, and the absence of proven clinical benefit from platelet transfusions in neonates.

Conclusions:

• Neonatal thrombocytopenia has diverse causes, with sepsis and NAIT being critical considerations.
• Platelet transfusion is standard for severe thrombocytopenia, but its efficacy in neonates remains unproven.
• Further research is essential to establish evidence-based guidelines for platelet transfusion in neonatal thrombocytopenia.